$ACMR

Wang David H sold $173K of ACMR

Wang David H (See Remarks) sold 2,060 shares of ACM Research, Inc. (ACMR) at $83.86 ($0.17M total) on 2026-06-04 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Wang David H
Published Jun 5, 2026, 8:30 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jun 5, 2026, 8:36 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$ACMR
Neutral
medium confidence
Mentioned
$ACMR
Relevance
6/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$ACMRNeutralLow
01

Why it matters

The disclosed sale reduces insider holdings from 840,650 shares post-transaction, but provides no new operational/financial catalyst.

02

Market read

A single, planned insider sale is generally a low-impact catalyst unless it’s part of a broader pattern or accompanied by other negative news.

03

What to watch

The filing doesn’t reveal motives, and the sale is pre-arranged; without follow-on buys/sales patterns, signal quality is low.

Relevance 6/10Novelty 4/10Timing: Filed after-hours (2026-06-05 20:30 UTC) for a sale executed on 2026-06-04.

Background

SEC Form 4 disclosures report insider transactions; 10b5-1 plans are pre-scheduled to mitigate timing-based trading concerns.

Company-level read

Ticker impact

$ACMRNeutralMedium confidence
Context

ACMR insider (officer/director/10% owner) sold 2,060 shares in an open-market transaction under a 10b5-1 plan.

Expected impact

Likely limited immediate impact; any effect would be sentiment-driven and small unless paired with other negative news.

Evidence & confidence

The filing is an SEC Form 4 for a planned 10b5-1 sale, which reduces the informational content versus an unplanned sale.

Market effects

No clear sector read-through from a single 10b5-1 insider sale.

None indicated.

None indicated.

Counterpoint

Even 10b5-1 sales can coincide with periods of perceived valuation risk; traders may still fade strength if selling volume is persistent.

Key entities

  • ACM Research, Inc.

    Issuer of the insider transaction disclosed via SEC Form 4.

  • Wang David H

    Officer/Director/10% Owner who executed an open-market sale under a 10b5-1 plan.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$ACMRMed

AI Sovereignty Becomes a New National Security Battleground: Morgan Stanley Names SpaceX and 4 Other Beneficiary Stocks, with Upside Potential Topping 100% — BigGo Finance

Morgan Stanley identifies SpaceX, ACM Research, Amkor Technology, Alibaba, and KLA as key beneficiaries of the AI sovereignty trend. The bank assigns price targets with upside potential ranging from 21% to 105%, highlighting the strategic importance of AI infrastructure for national security and economic competitiveness.

$ACMRMed

ACM Research (NASDAQ: ACMR) unit’s orders surge past 100% with 42–48% margin outlook

ACM Research (Shanghai) reported a 105% year-over-year increase in new orders for the first half of 2026, with growth across electroplating, cleaning, and advanced packaging equipment. The company expects gross margins to remain between 42% and 48%. Significant orders include panel-level electroplating systems for delivery in 2026 and 2027. ACM Shanghai also highlighted rapid growth in mature-node semiconductor manufacturing and AI-related equipment demand.

$ACMRMedAI 9/10

ACM Research (ACMR) Q2 2026 Earnings Call Transcript

ACM Research (ACMR) reported Q2 2026 revenue of $292.9M, up 36% year over year, with non-GAAP diluted EPS of $0.61. Non-GAAP gross margin was 46.0%. The company raised 2026 revenue guidance to $1.125B-$1.175B and said first-half orders rose 105%. Net cash was $1.0B.